Susquehanna Fundamental Investments’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.8K | Hold |
17,087
| – | – | ﹤0.01% | 701 |
|
|
2025
Q1 | $93.8K | Sell |
17,087
-2,625
| -13% | -$14.4K | ﹤0.01% | 1029 |
|
|
2024
Q4 | $66.8K | Buy |
+19,712
| New | +$66.8K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $170K | Sell |
66,540
-120,117
| -64% | -$307K | ﹤0.01% | 1393 |
|
|
2021
Q4 | $547K | Sell |
186,657
-87,816
| -32% | -$257K | 0.01% | 881 |
|
|
2021
Q3 | $672K | Buy |
274,473
+130,834
| +91% | +$320K | 0.01% | 1065 |
|
|
2021
Q2 | $585K | Buy |
+143,639
| New | +$585K | 0.01% | 1093 |
|
|
2021
Q1 | – | Sell |
-14,132
| Closed | -$70K | – | 1629 |
|
|
2020
Q4 | $70K | Buy |
+14,132
| New | +$70K | ﹤0.01% | 1442 |
|